Literature DB >> 12852442

Drug absorption from the isolated perfused rat lung--correlations with drug physicochemical properties and epithelial permeability.

Ann Tronde1, Bo Nordén, Ann-Britt Jeppsson, Per Brunmark, Elisabeth Nilsson, Hans Lennernäs, Ursula Hultkvist Bengtsson.   

Abstract

The pulmonary absorption of nine low-molecular-weight (225-430 Da) drugs (atenolol, budesonide, enalaprilat, enalapril, formoterol, losartan, metoprolol, propranolol and terbutaline) and one high-molecular-weight membrane permeability marker compound (FITC-dextran 10000 Da) was investigated using the isolated, perfused and ventilated rat lung (IPL). The relationships between pulmonary transport characteristics, epithelial permeability of Caco-2 cell monolayers and drug physicochemical properties were evaluated using multivariate data analysis. Finally, an in vitro-in vivo correlation was made using in vivo rat lung absorption data. The absorption half-life of the investigated drugs ranged from 2 to 59 min, and the extent of absorption from 21 to 94% in 2 h in the isolated perfused rat lung model. The apparent first-order absorption rate constant in IPL (ka(lung)) was found to correlate to the apparent permeability (P(app)) of Caco-2 cell monolayers (r = 0.87), cLog D(7.4) (r = 0.70), cLog P, and to the molecular polar surface area (%PSA) (r = -0.79) of the drugs. A Partial Least Squares (PLS)-model for prediction of the absorption rate (log ka(lung)) from the descriptors log P(app), %PSA and cLogD(7.4) was found (Q2 = 0.74, R2 = 0.78). Furthermore, a strong in vitro-in vivo correlation (r = 0.98) was found for the in vitro (IPL) drug absorption half-life and the pulmonary absorption half-life obtained in rats in vivo, based on a sub-set of five compounds.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12852442     DOI: 10.1080/1061186031000086117

Source DB:  PubMed          Journal:  J Drug Target        ISSN: 1026-7158            Impact factor:   5.121


  16 in total

1.  Population pharmacokinetics of colistin methanesulfonate in rats: achieving sustained lung concentrations of colistin for targeting respiratory infections.

Authors:  Shalini Yapa; Jian Li; Christopher J H Porter; Roger L Nation; Kashyap Patel; Michelle P McIntosh
Journal:  Antimicrob Agents Chemother       Date:  2013-08-05       Impact factor: 5.191

Review 2.  In Vitro Testing for Orally Inhaled Products: Developments in Science-Based Regulatory Approaches.

Authors:  Ben Forbes; Per Bäckman; David Christopher; Myrna Dolovich; Bing V Li; Beth Morgan
Journal:  AAPS J       Date:  2015-05-05       Impact factor: 4.009

3.  Biopharmaceutical characterization of nebulized antimicrobial agents in rats: 2. Colistin.

Authors:  Aline Vidal Lacerda Gontijo; Nicolas Grégoire; Isabelle Lamarche; Patrice Gobin; William Couet; Sandrine Marchand
Journal:  Antimicrob Agents Chemother       Date:  2014-05-05       Impact factor: 5.191

4.  CAR, a Homing Peptide, Prolongs Pulmonary Preferential Vasodilation by Increasing Pulmonary Retention and Reducing Systemic Absorption of Liposomal Fasudil.

Authors:  Ali Keshavarz; Ahmed Alobaida; Ivan F McMurtry; Eva Nozik-Grayck; Kurt R Stenmark; Fakhrul Ahsan
Journal:  Mol Pharm       Date:  2019-06-27       Impact factor: 4.939

5.  Chapter 9 - Nanoliposomal dry powder formulations.

Authors:  Gaurang Patel; Mahavir Chougule; Mandip Singh; Ambikanandan Misra
Journal:  Methods Enzymol       Date:  2009       Impact factor: 1.600

6.  Cell-based multiscale computational modeling of small molecule absorption and retention in the lungs.

Authors:  Jing-Yu Yu; Gus R Rosania
Journal:  Pharm Res       Date:  2010-01-23       Impact factor: 4.200

7.  Human Airway Primary Epithelial Cells Show Distinct Architectures on Membrane Supports Under Different Culture Conditions.

Authors:  Kyoung Ah Min; Gus R Rosania; Meong Cheol Shin
Journal:  Cell Biochem Biophys       Date:  2016-01-27       Impact factor: 2.194

8.  Drug delivery characteristics of the progenitor bronchial epithelial cell line VA10.

Authors:  Berglind Eva Benediktsdóttir; Ari Jón Arason; Skarphédinn Halldórsson; Thórarinn Gudjónsson; Már Másson; Olafur Baldursson
Journal:  Pharm Res       Date:  2012-11-08       Impact factor: 4.200

Review 9.  Animal Models Reflecting Chronic Obstructive Pulmonary Disease and Related Respiratory Disorders: Translating Pre-Clinical Data into Clinical Relevance.

Authors:  Lloyd Tanner; Andrew Bruce Single
Journal:  J Innate Immun       Date:  2019-09-17       Impact factor: 7.349

10.  Prediction of CYP-mediated silybin A-losartan pharmacokinetic interactions using physiological based pharmacokinetic modeling.

Authors:  Ayesha Tanveer; Khalid Hussain; Hirra Tasneem; Iqra Arif; Memoona Rashid; Nasir Abbas; Rahat Shamim; Pervaiz A Shah; Nadeem Irfan Bukhari
Journal:  J Pharmacokinet Pharmacodyn       Date:  2022-01-21       Impact factor: 2.745

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.